Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francisco Javier Ibarrondo

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Oncotargets and Therapy|April 5, 2016
Tremelimumab: research and clinical developmentBegoña Comin-Anduix, Helena Escuin-Ordinas, Francisco Javier Ibarrondo
Frontiers in Immunology|March 11, 2022
Dominant CD8<sup>+</sup> T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From VaccinationEllie Taus, Christian Hofmann, Francisco Javier Ibarrondo, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Oncotargets and Therapy|April 5, 2016
Tremelimumab: research and clinical developmentBegoña Comin-Anduix, Helena Escuin-Ordinas, Francisco Javier Ibarrondo
Frontiers in Immunology|March 11, 2022
Dominant CD8<sup>+</sup> T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From VaccinationEllie Taus, Christian Hofmann, Francisco Javier Ibarrondo, et al.
Pageof 1